PubMed:17255138 / 0-172 JSONTXT

{"project":"LitCoin-entities","denotations":[{"id":"3881","span":{"begin":22,"end":38},"obj":"ChemicalEntity"},{"id":"3882","span":{"begin":56,"end":62},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"db_id","subj":"3881","obj":"MESH:D052246"},{"id":"A2","pred":"db_id","subj":"3882","obj":"MESH:D000894"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":133},"obj":"Sentence"},{"id":"T2","span":{"begin":134,"end":163},"obj":"Sentence"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":28,"end":38},"obj":"GeneOrGeneProduct"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":28,"end":38},"obj":"GeneOrGeneProduct"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":22,"end":38},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":56,"end":62},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"ChemicalEntity"},{"id":"A2","pred":"ID:","subj":"T2","obj":"ChemicalEntity"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T2","span":{"begin":56,"end":62},"obj":"ChemicalEntity"},{"id":"T1","span":{"begin":22,"end":38},"obj":"ChemicalEntity"},{"id":"T13836","span":{"begin":22,"end":27},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T2","obj":"ChemicalEntity"},{"id":"A1","pred":"ID:","subj":"T1","obj":"ChemicalEntity"}],"text":"Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.\nOBJECTIV"}